Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Natural trans fat, dairy fat, partially hydrogenated oils, and cardiometabolic health: the Ludwigshafen Risk and Cardiovascular Health Study: Table 1

Open access
Mozaffarian, Dariush · 2016 · European Heart Journal

Abstract

This editorial refers to ‘Trans-fatty acids and mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study’†, by M.E. Kleber et al., on page 1072. Kleber and colleagues have investigated levels of trans-fatty acids (TFAs) in erythrocyte membranes and risk of total mortality, cardiovascular mortality, and sudden cardiac death (SCD) in a convenience cohort of German patients hospitalized for angiography.1 After multivariable adjustment, they found that higher levels of total TFAs, and specifically C16 : 1n-7t, were associated with lower risk of SCD (for C16:1n-7t, ∼37% lower risk in the top tertile, compared with the bottom). No other significant associations were identified, including for total TFAs or C16:1n-7t and total or cardiovascular mortality, or for C18:1t or C18:2t and total mortality, cardiovascular mortality, or SCD. How should these findings be interpreted, and what are their implications? In any research study—whether in vitro science, animal experiment, metabolic study, clinical trial, or observational epidemiology—the devil is in the details. Such crucial details are frequently overlooked in our modern age of compressed news, internet, and social media reporting. In this case, the first important detail is the population studied. TFA levels were not measured in a general community, but in patients with chest pain or a positive non-invasive cardiac stress test who were hospitalized for coronary angiography between 1997 and 2000 at a tertiary care centre. Accordingly, these were not generally healthy individuals: for instance, at baseline, 73% had high blood pressure, 50% were taking lipid-lowering medication, and 40% had diabetes. Such patients would often be conscious of their symptoms and health prior to hospitalization, and consequently have altered their dietary behaviours and other lifestyle factors in response to their concern. Such a population produces a classic set-up for ‘reverse causation’: underlying poor health leading to changed behaviours and avoidance of TFA-containing foods (e.g. processed foods, whole-fat dairy), rather than TFA levels predicting future poor health. Is there evidence for such reverse causation in the present study? Yes: those with the lowest TFA levels, i.e. those eating the fewest processed foods and whole-fat dairy, were generally much sicker: they had a higher body mass index, higher blood pressure, more smoking, and substantially more diabetes and worse glucose–insulin homeostasis. TFAs are also known to increase LDL-cholesterol and decrease HDL-cholesterol.2 Yet, in these patients, lower TFA levels were associated with lower HDL-cholesterol and more lipid-lowering therapy—further suggesting reverse causation. This directly contrasts with more general, community-based cohorts (in which reverse causation from pre-existing disease would be less likely), in which higher erythrocyte or phospholipid TFA levels are associated with higher LDL-cholesterol and lower HDL-cholesterol,3,4 as expected. When substantial reverse causation may be present, fully accounting for its effects can be challenging. Thus, the second important detail is the multivariable adjustment that was—and was not—performed. Given the multiple strong associations of lower TFA levels with poor health markers in this population, the first model—only adjusted for age and gender—is not very informative, almost surely burdened by substantial confounding. The second model (‘Model 2’) included many relevant variables. However, it only roughly accounted for significant observed differences in metabolic dysfunction (diabetes, yes/no; hypertension, yes/no), rather than using more discriminative data on levels of systolic and diastolic blood pressure, haemoglobin A1c, and HOMA (homeostatic model assessment) insulin resistance. Not including these produces residual confounding by these factors. Consistent with this, when the authors further adjusted for haemoglobin A1c, antihypertensive medication use, and alcohol, the inverse association of C16:1n-7t with SCD was further attenuated (P for trend = 0.035; Supplementary table S9). It seems plausible that, with further adjustment for blood pressure levels and HOMA insulin resistance, this borderline association would no longer have been statistically significant. The authors also adjusted for levels of blood cholesterol—a major pathway whereby TFAs would influence cardiovascular risk.2 Such adjustment for potential ‘mediating’ variables would attenuate true associations toward the null, making it harder to detect potential harmful effects. Finally, none of the models adjusted for other dietary habits, which were not assessed in these patients. Differences in other diet behaviours across the tertiles of TFAs could appreciably alter the findings, in unpredictable directions. Based on these challenges, i.e. the multiple (12) different TFA–endpoint pairs evaluated, the evidence suggesting reverse causation, the

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehv595

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Research works printed but not linked: 1

  1. US Food and Drug Administration. FDA Cuts Trans Fat in Processed Foods. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm372915.htm .

Cited by

See all 40

Metadata

Authors
Mozaffarian, D.
Affiliations
Tufts University (US)
Corresponding author
Mozaffarian, Dariush
Venue
European Heart Journal
Published
2015-11-17
Volume
37
Issue
13
Pages
1079-1081
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2177500602
Cited by
40
References
18
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 6 · 2018: 5 · 2017: 3 · 2016: 5
Type
journal article
Language
en
Open access
Locations
  • European Heart Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
National Heart, Lung, and Blood Institute (R01HL085710)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords
trans fatty acids, sudden cardiac death, cardiovascular mortality, all-cause mortality, reverse causality, coronary angiography patients, processed foods, dietary behaviour, cardiovascular risk factors, cardiometabolic health, erythrocyte membrane lipids, cardiovascular disease prevention
MeSH terms
Dietary Fats, Fatty Acids, Humans, Hydrogen, Hydrogenation, Oils, Risk, Trans Fatty Acids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Natural trans fat, dairy fat, partially hydrogenated oils, and cardiometabolic health: the Ludwigshafen Risk and Cardiovascular Health Study: Table 1. https://app.cochat.ai/papers/10.1093/eurheartj/ehv595
The paper
Mozaffarian, D. (2016). Natural trans fat, dairy fat, partially hydrogenated oils, and cardiometabolic health: the Ludwigshafen Risk and Cardiovascular Health Study: Table 1. European Heart Journal. https://doi.org/10.1093/eurheartj/ehv595

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.